Skip to main content
Caplight Logo









Veneno Technologies Co., Ltd.

Veneno Technologies Co., Ltd.

Private
TsukubaHealthcare & Life Scienceshttps://veneno.co.jp/en/top-en/

Last Round

Seed

Jan 24, 2022

Total Funding Raised

$1.76M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Veneno Technologies Co., Ltd. is a biotechnology company that develops therapeutic disulfide-rich peptides (DRPs) using its proprietary Veneno Suite platform for applications in pharmaceuticals, agrochemicals, and animal health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

disulfide-rich peptidesDRPdrug discoverypeptide engineeringdrug discovery platformpeptide therapeuticsbiotechnology platformhigh-throughput screeningprotein engineeringdrug discovery techmolecular engineeringbiopesticidestherapeutic modalitiestransmembrane protein targetingbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veneno Technologies Co., Ltd. Comparables

Compare Veneno Technologies Co., Ltd. with similar companies based on industry and business-model similarity.

Veneno Technologies Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MiraBiologics Inc.
81%
Zonsen PepLib Biotech Inc.
81%
Epsilon Molecular Engineering, Inc.
81%

Veneno Technologies Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 24, 2022

Key People

Founding team and executive leadership

Takatoshi Kuno

Representative Director, CEO

Executive Team

Tadashi Kimura

CSO CTO

Executive Team

Veneno Technologies Co., Ltd. Investors

Notable investors and investment history

Veneno Technologies Co., Ltd. investors
InvestorRounds
SBI Regional Revitalization Support CorporationSeed
SBI Investment Co., Ltd.Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2026

    Grew 50% QoQ, from 8 to 12 employees.

  • Jun 10, 2026

    Grew 38% QoQ, from 8 to 11 employees.

Veneno Technologies Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Veneno Technologies Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Veneno Technologies Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTsukuba
Employee Range12
Year Founded2020
Last FundingJan 24, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?